Infectious Disease Rapid Diagnostic Testing Market to Reach $2,853.2Mn by 2025

According to a new market intelligence report by BIS Research titled “Global Infectious Disease Rapid Diagnostic Testing Market- Analysis and Forecast, 2020-2025”, the global infectious disease rapid diagnostic testing market was valued at $1.249.3 million in 2019 and is anticipated to grow over $2,853.2 million by 2025. The global infectious disease rapid diagnostic testing market is expected to grow at double-digit compound annual growth rate in the forecast period 2020-2025, aided primarily by the impressive growth in the underlying manufacturing market.

Infectious disease rapid diagnostic testing has emerged as one of the most promising techniques in the field of diagnostics. Infectious disease rapid diagnostic testing is primarily adopted for the diagnosis of various infectious diseases in a restricted clinical environment. The testing primarily relies on the detection of target analyte, offering clinical insights in a stipulated time frame. Such testing is becoming an integral component of the healthcare system across the globe. The adoption of these tests in the healthcare system has aided clinicals in navigating through tough times during the outbreak of highly contagious infections such as Ebola virus disease (EVD), SARS-CoV, Middle East respiratory syndrome coronavirus (MERS-CoV), and COVID-19, among others.

“North America is the leading contributor in the infectious disease rapid diagnostic testing market and contributed approximately 42.09% to the global market value in 2019. This region is anticipated to grow at a CAGR of 12.16% during the forecast period 2020-2025 and is expected to continue dominating the global market in 2025. However, the Asia-Pacific region is expected to grow at an impressive CAGR of 13.85% during the forecast period from 2020-2025. The Europe region also contributed a significant share of 17.96% to the global market in 2019 and is anticipated to grow at a CAGR of 12.05% during the forecast period from 2020-2025."

Research Highlights:

  • Infectious disease rapid diagnostic testing market for assays is expected to witness a robust CAGR of 12.44% during the forecast period 2020-2025. However, infectious disease rapid diagnostic testing market for platforms is anticipated to witness the growth of 12.09% during the forecast period, 2020-2025.
  • Abbott Laboratories is currently the largest shareholder in the global infectious disease rapid diagnostic testing market. This market dominance is attributed to the company’s presence within the market through its dedicated product mix based on its proprietary technologies.

This market intelligence report provides a multi-dimensional view of the global infectious disease rapid diagnostic testing market in terms of market size and growth potential. This research report aims at answering various aspects of the global infectious disease rapid diagnostic testing market with the help of key factors driving the market, restraints that can possibly inhibit the overall growth of the market, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Sample Report @ https://bisresearch.com/requestsample?id=875&type=download

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches and enhancements, collaborations and agreements, acquisitions and business expansions. The research report provides a comprehensive analysis of the product sales, manufacturers, and trend analysis by segment, market share and growth share analysis by companies. Additionally, the report provides a comprehensive attractive analysis and opportunity analysis for the entire infectious disease rapid diagnostic testing market for 2020 and 2025.

This report is a meticulous compilation of research on more than 35 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 20 leading and emerging companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc, Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton, Dickinson and Company, and Cellex.

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

Contact:
Bhavya Banga
Email: media@bisresearch.com

Related Posts

Subscribe Our Newsletter